Artificial Cardiac Valves-EMEA Market Status and Trend Report 2013-2023
Report Summary
Artificial Cardiac Valves-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Artificial Cardiac Valves industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
EMEA Artificial Cardiac Valves Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Artificial Cardiac Valves Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Mechanical Heart Valves
Biological/Tissue Heart Valves
Transcatheter Heart Valves
EMEA Artificial Cardiac Valves Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Ambulatory Surgery Centres
Others
EMEA Artificial Cardiac Valves Market: Players Segment Analysis (Company and Product introduction, Artificial Cardiac Valves Sales Volume, Revenue, Price and Gross Margin):
Boston Scientific
St. Jude Medical
Medtronic
Edwards Lifesciences
Abbott Laboratories
Symetis
LivaNova
CryoLife
Braile Biomedica
Colibri Heart Valve
JenaValve Technology
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Artificial Cardiac Valves-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Artificial Cardiac Valves industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
- Whole EMEA and Regional Market Size of Artificial Cardiac Valves 2013-2017, and development forecast 2018-2023
- Main market players of Artificial Cardiac Valves in EMEA, with company and product introduction, position in the Artificial Cardiac Valves market
- Market status and development trend of Artificial Cardiac Valves by types and applications
- Cost and profit status of Artificial Cardiac Valves, and marketing status
- Market growth drivers and challenges
EMEA Artificial Cardiac Valves Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Artificial Cardiac Valves Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Mechanical Heart Valves
Biological/Tissue Heart Valves
Transcatheter Heart Valves
EMEA Artificial Cardiac Valves Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Ambulatory Surgery Centres
Others
EMEA Artificial Cardiac Valves Market: Players Segment Analysis (Company and Product introduction, Artificial Cardiac Valves Sales Volume, Revenue, Price and Gross Margin):
Boston Scientific
St. Jude Medical
Medtronic
Edwards Lifesciences
Abbott Laboratories
Symetis
LivaNova
CryoLife
Braile Biomedica
Colibri Heart Valve
JenaValve Technology
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ARTIFICIAL CARDIAC VALVES
1.1 Definition of Artificial Cardiac Valves in This Report
1.2 Commercial Types of Artificial Cardiac Valves
1.2.1 Mechanical Heart Valves
1.2.2 Biological/Tissue Heart Valves
1.2.3 Transcatheter Heart Valves
1.3 Downstream Application of Artificial Cardiac Valves
1.3.1 Hospitals
1.3.2 Ambulatory Surgery Centres
1.3.3 Others
1.4 Development History of Artificial Cardiac Valves
1.5 Market Status and Trend of Artificial Cardiac Valves 2013-2023
1.5.1 EMEA Artificial Cardiac Valves Market Status and Trend 2013-2023
1.5.2 Regional Artificial Cardiac Valves Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Artificial Cardiac Valves in EMEA 2013-2017
2.2 Consumption Market of Artificial Cardiac Valves in EMEA by Regions
2.2.1 Consumption Volume of Artificial Cardiac Valves in EMEA by Regions
2.2.2 Revenue of Artificial Cardiac Valves in EMEA by Regions
2.3 Market Analysis of Artificial Cardiac Valves in EMEA by Regions
2.3.1 Market Analysis of Artificial Cardiac Valves in Europe 2013-2017
2.3.2 Market Analysis of Artificial Cardiac Valves in Middle East 2013-2017
2.3.3 Market Analysis of Artificial Cardiac Valves in Africa 2013-2017
2.4 Market Development Forecast of Artificial Cardiac Valves in EMEA 2018-2023
2.4.1 Market Development Forecast of Artificial Cardiac Valves in EMEA 2018-2023
2.4.2 Market Development Forecast of Artificial Cardiac Valves by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Artificial Cardiac Valves in EMEA by Types
3.1.2 Revenue of Artificial Cardiac Valves in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Artificial Cardiac Valves in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Artificial Cardiac Valves in EMEA by Downstream Industry
4.2 Demand Volume of Artificial Cardiac Valves by Downstream Industry in Major Countries
4.2.1 Demand Volume of Artificial Cardiac Valves by Downstream Industry in Europe
4.2.2 Demand Volume of Artificial Cardiac Valves by Downstream Industry in Middle East
4.2.3 Demand Volume of Artificial Cardiac Valves by Downstream Industry in Africa
4.3 Market Forecast of Artificial Cardiac Valves in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ARTIFICIAL CARDIAC VALVES
5.1 EMEA Economy Situation and Trend Overview
5.2 Artificial Cardiac Valves Downstream Industry Situation and Trend Overview
CHAPTER 6 ARTIFICIAL CARDIAC VALVES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Artificial Cardiac Valves in EMEA by Major Players
6.2 Revenue of Artificial Cardiac Valves in EMEA by Major Players
6.3 Basic Information of Artificial Cardiac Valves by Major Players
6.3.1 Headquarters Location and Established Time of Artificial Cardiac Valves Major Players
6.3.2 Employees and Revenue Level of Artificial Cardiac Valves Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ARTIFICIAL CARDIAC VALVES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Boston Scientific
7.1.1 Company profile
7.1.2 Representative Artificial Cardiac Valves Product
7.1.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of Boston Scientific
7.2 St. Jude Medical
7.2.1 Company profile
7.2.2 Representative Artificial Cardiac Valves Product
7.2.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of St. Jude Medical
7.3 Medtronic
7.3.1 Company profile
7.3.2 Representative Artificial Cardiac Valves Product
7.3.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of Medtronic
7.4 Edwards Lifesciences
7.4.1 Company profile
7.4.2 Representative Artificial Cardiac Valves Product
7.4.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of Edwards Lifesciences
7.5 Abbott Laboratories
7.5.1 Company profile
7.5.2 Representative Artificial Cardiac Valves Product
7.5.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.6 Symetis
7.6.1 Company profile
7.6.2 Representative Artificial Cardiac Valves Product
7.6.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of Symetis
7.7 LivaNova
7.7.1 Company profile
7.7.2 Representative Artificial Cardiac Valves Product
7.7.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of LivaNova
7.8 CryoLife
7.8.1 Company profile
7.8.2 Representative Artificial Cardiac Valves Product
7.8.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of CryoLife
7.9 Braile Biomedica
7.9.1 Company profile
7.9.2 Representative Artificial Cardiac Valves Product
7.9.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of Braile Biomedica
7.10 Colibri Heart Valve
7.10.1 Company profile
7.10.2 Representative Artificial Cardiac Valves Product
7.10.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of Colibri Heart Valve
7.11 JenaValve Technology
7.11.1 Company profile
7.11.2 Representative Artificial Cardiac Valves Product
7.11.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of JenaValve Technology
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ARTIFICIAL CARDIAC VALVES
8.1 Industry Chain of Artificial Cardiac Valves
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ARTIFICIAL CARDIAC VALVES
9.1 Cost Structure Analysis of Artificial Cardiac Valves
9.2 Raw Materials Cost Analysis of Artificial Cardiac Valves
9.3 Labor Cost Analysis of Artificial Cardiac Valves
9.4 Manufacturing Expenses Analysis of Artificial Cardiac Valves
CHAPTER 10 MARKETING STATUS ANALYSIS OF ARTIFICIAL CARDIAC VALVES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Artificial Cardiac Valves in This Report
1.2 Commercial Types of Artificial Cardiac Valves
1.2.1 Mechanical Heart Valves
1.2.2 Biological/Tissue Heart Valves
1.2.3 Transcatheter Heart Valves
1.3 Downstream Application of Artificial Cardiac Valves
1.3.1 Hospitals
1.3.2 Ambulatory Surgery Centres
1.3.3 Others
1.4 Development History of Artificial Cardiac Valves
1.5 Market Status and Trend of Artificial Cardiac Valves 2013-2023
1.5.1 EMEA Artificial Cardiac Valves Market Status and Trend 2013-2023
1.5.2 Regional Artificial Cardiac Valves Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Artificial Cardiac Valves in EMEA 2013-2017
2.2 Consumption Market of Artificial Cardiac Valves in EMEA by Regions
2.2.1 Consumption Volume of Artificial Cardiac Valves in EMEA by Regions
2.2.2 Revenue of Artificial Cardiac Valves in EMEA by Regions
2.3 Market Analysis of Artificial Cardiac Valves in EMEA by Regions
2.3.1 Market Analysis of Artificial Cardiac Valves in Europe 2013-2017
2.3.2 Market Analysis of Artificial Cardiac Valves in Middle East 2013-2017
2.3.3 Market Analysis of Artificial Cardiac Valves in Africa 2013-2017
2.4 Market Development Forecast of Artificial Cardiac Valves in EMEA 2018-2023
2.4.1 Market Development Forecast of Artificial Cardiac Valves in EMEA 2018-2023
2.4.2 Market Development Forecast of Artificial Cardiac Valves by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Artificial Cardiac Valves in EMEA by Types
3.1.2 Revenue of Artificial Cardiac Valves in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Artificial Cardiac Valves in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Artificial Cardiac Valves in EMEA by Downstream Industry
4.2 Demand Volume of Artificial Cardiac Valves by Downstream Industry in Major Countries
4.2.1 Demand Volume of Artificial Cardiac Valves by Downstream Industry in Europe
4.2.2 Demand Volume of Artificial Cardiac Valves by Downstream Industry in Middle East
4.2.3 Demand Volume of Artificial Cardiac Valves by Downstream Industry in Africa
4.3 Market Forecast of Artificial Cardiac Valves in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ARTIFICIAL CARDIAC VALVES
5.1 EMEA Economy Situation and Trend Overview
5.2 Artificial Cardiac Valves Downstream Industry Situation and Trend Overview
CHAPTER 6 ARTIFICIAL CARDIAC VALVES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Artificial Cardiac Valves in EMEA by Major Players
6.2 Revenue of Artificial Cardiac Valves in EMEA by Major Players
6.3 Basic Information of Artificial Cardiac Valves by Major Players
6.3.1 Headquarters Location and Established Time of Artificial Cardiac Valves Major Players
6.3.2 Employees and Revenue Level of Artificial Cardiac Valves Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ARTIFICIAL CARDIAC VALVES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Boston Scientific
7.1.1 Company profile
7.1.2 Representative Artificial Cardiac Valves Product
7.1.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of Boston Scientific
7.2 St. Jude Medical
7.2.1 Company profile
7.2.2 Representative Artificial Cardiac Valves Product
7.2.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of St. Jude Medical
7.3 Medtronic
7.3.1 Company profile
7.3.2 Representative Artificial Cardiac Valves Product
7.3.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of Medtronic
7.4 Edwards Lifesciences
7.4.1 Company profile
7.4.2 Representative Artificial Cardiac Valves Product
7.4.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of Edwards Lifesciences
7.5 Abbott Laboratories
7.5.1 Company profile
7.5.2 Representative Artificial Cardiac Valves Product
7.5.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.6 Symetis
7.6.1 Company profile
7.6.2 Representative Artificial Cardiac Valves Product
7.6.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of Symetis
7.7 LivaNova
7.7.1 Company profile
7.7.2 Representative Artificial Cardiac Valves Product
7.7.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of LivaNova
7.8 CryoLife
7.8.1 Company profile
7.8.2 Representative Artificial Cardiac Valves Product
7.8.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of CryoLife
7.9 Braile Biomedica
7.9.1 Company profile
7.9.2 Representative Artificial Cardiac Valves Product
7.9.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of Braile Biomedica
7.10 Colibri Heart Valve
7.10.1 Company profile
7.10.2 Representative Artificial Cardiac Valves Product
7.10.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of Colibri Heart Valve
7.11 JenaValve Technology
7.11.1 Company profile
7.11.2 Representative Artificial Cardiac Valves Product
7.11.3 Artificial Cardiac Valves Sales, Revenue, Price and Gross Margin of JenaValve Technology
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ARTIFICIAL CARDIAC VALVES
8.1 Industry Chain of Artificial Cardiac Valves
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ARTIFICIAL CARDIAC VALVES
9.1 Cost Structure Analysis of Artificial Cardiac Valves
9.2 Raw Materials Cost Analysis of Artificial Cardiac Valves
9.3 Labor Cost Analysis of Artificial Cardiac Valves
9.4 Manufacturing Expenses Analysis of Artificial Cardiac Valves
CHAPTER 10 MARKETING STATUS ANALYSIS OF ARTIFICIAL CARDIAC VALVES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
